Publication | Closed Access

Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial

Breast OncologyOncologyPharmacologyRecurrent Breast CancerBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentMedicine